Related Experiment Video
Updated: Aug 25, 2026

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
[Do drug-eluting stents influence the spectrum of coronary artery bypass surgery?]
Klaus Matschke1, Sems Malte Tugtekin, Utz Kappert
1Klinik für Herz- und Thorakale Gefässchirurgie, Herzzentrum Dresden GmbH, Universitätsklinik, Dresden. monika.webre.hkz_dd@t-online.de
Insights
Drug-eluting stents show improved patency over traditional stents but their benefit compared to bypass surgery for coronary artery disease remains unclear. Further research is needed to determine their impact on surgical coronary revascularization procedures.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Coronary revascularization procedures, including bypass surgery, are established treatments for coronary artery disease.
- The introduction of drug-eluting stents has raised questions about their impact on the utilization and role of surgical revascularization.
Purpose of the Study:
- To evaluate the current impact of drug-eluting stents on the spectrum of surgical coronary revascularization procedures.
- To compare the efficacy of drug-eluting stents with bypass surgery for treating coronary artery disease.
Main Methods:
- Review of recent studies on drug-eluting stent technology.
- Comparative analysis of outcomes between surgical revascularization and interventional cardiology procedures.
Main Results:
- Drug-eluting stents demonstrate significantly better patency rates compared to conventional stents.
- Current evidence does not establish a benefit of drug-eluting stents over bypass surgery for patients with similar indications.
Conclusions:
- The precise impact of drug-eluting stents on the landscape of bypass surgery is currently indeterminate.
- Further comparative studies are required to fully elucidate the role of drug-eluting stents versus surgical intervention in coronary artery disease management.
Background:
The number of surgical coronary revascularization procedures is static and even declining. Since the introduction of drug eluting stents the question arose whether this will have an impact on the spectrum of surgical coronary revascularization procedures.
Bypass Surgery:
Bypass surgery is a routine procedure for the treatment of coronary artery disease with good results. Studies have shown that there is a benefit in favor of surgery compared to interventional cardiologic procedures. DRUG-ELUTING STENTS: In recent studies a new generation of stents, drug-eluting stents, have proven to have a significant better patency rate than common stents. However, to date there are no studies which show a benefit compared to surgery given the same indication for treatment.
Conclusion:
Therefore, the question whether drug-eluting stents have an impact on the spectrum of bypass surgery cannot be fully answered at present.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview